These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32020150)

  • 1. The use of intravenous immunoglobulin therapy in a tertiary pediatric hospital.
    Güngör A; Yarali N
    Saudi Med J; 2020 Feb; 41(2):163-167. PubMed ID: 32020150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse reactions and influencing factors in children with primary immunodeficiencies receiving intravenous immunglobulin replacement.
    Ibis IBP; Erdur B; Erdem SB; Karaman S; Gulez N; Genel F
    Allergol Immunopathol (Madr); 2020; 48(6):738-744. PubMed ID: 32703652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intravenous immunoglobulin in an Asian paediatric population over a 10-year period.
    Wu J; Lee AJ; Goh AE; Chia M; Ho C; Bugarin JL; Shek LP; Chan YH; Lee BW
    J Paediatr Child Health; 2013 Aug; 49(8):629-34. PubMed ID: 23750995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
    Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
    Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inpatient paediatric use of intravenous immunoglobulin at an academic medical centre.
    Dashti-Khavidaki S; Khalili H; Farshadi F; Aghamohammadi A; Movahedi M; Hajibabaei M
    Singapore Med J; 2008 Feb; 49(2):147-9. PubMed ID: 18301844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing trends in IVIG use in pediatric patients: A retrospective review of practices in a network of major USA pediatric hospitals.
    Balch A; Wilkes J; Thorell E; Pavia A; Sherwin CMT; Enioutina EY
    Int Immunopharmacol; 2019 Nov; 76():105868. PubMed ID: 31487613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not all intravenous immunoglobulin preparations are equally well tolerated.
    Feldmeyer L; Benden C; Haile SR; Boehler A; Speich R; French LE; Hofbauer GF
    Acta Derm Venereol; 2010 Sep; 90(5):494-7. PubMed ID: 20814625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
    Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
    Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical indications for intravenous immunoglobulin utilization in a tertiary medical center: a 9-year retrospective study.
    Shemer A; Kivity S; Shoenfeld Y
    Transfusion; 2018 Feb; 58(2):430-438. PubMed ID: 29193136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Polyclonal Intravenous Immunoglobulin at a Paediatric Referral Hospital in South Africa Between 2009 and 2012.
    Raiman S; Knight SE; Eley B; Welzel TB
    J Clin Immunol; 2015 Oct; 35(7):668-74. PubMed ID: 26369911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate adverse reactions to intravenous immunoglobulin in children: a single center experience.
    Kaba S; Keskindemirci G; Aydogmus C; Siraneci R; Erol Cipe F
    Eur Ann Allergy Clin Immunol; 2017 Jan; 49(1):11-14. PubMed ID: 28120600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous Immunoglobulin in the Treatment of Hematologic Disorders in Pediatrics.
    Villanueva G; de Jong JL; McNeer JL
    Pediatr Ann; 2017 Jan; 46(1):e13-e18. PubMed ID: 28079913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous immunoglobulin replacement therapy in 114 cases of congenital agammaglobulinemia].
    Li YW; Chen H; Zhang Y; An YF; Tang XM; Zhao XD; Zhang ZY
    Zhonghua Er Ke Za Zhi; 2021 Jun; 59(6):495-500. PubMed ID: 34102824
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictive factors of first dosage intravenous immunoglobulin-related adverse effects in children.
    Kubota J; Hamano SI; Daida A; Hiwatari E; Ikemoto S; Hirata Y; Matsuura R; Hirano D
    PLoS One; 2020; 15(1):e0227796. PubMed ID: 31929600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of childhood dermatomyositis with high dose intravenous immunoglobulin.
    Vedanarayanan V; Subramony SH; Ray LI; Evans OB
    Pediatr Neurol; 1995 Nov; 13(4):336-9. PubMed ID: 8771171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin utilization in a tertiary care teaching hospital in Saudi Arabia.
    Alangari AA; Abutaleb MH; Albarraq AA; Al-Dhowailie AA
    Saudi Med J; 2008 Jul; 29(7):975-9. PubMed ID: 18626524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin therapy in systemic onset juvenile rheumatoid arthritis: a followup study.
    Uziel Y; Laxer RM; Schneider R; Silverman ED
    J Rheumatol; 1996 May; 23(5):910-8. PubMed ID: 8724308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of non-specific intravenous human immunoglobulins in Spanish hospitals; need for a hospital protocol.
    Ruiz-Antorán B; Agustí Escasany A; Vallano Ferraz A; Danés Carreras I; Riba N; Mateu Escudero S; Costa J; Sánchez Santiago MB; Laredo L; Durán Quintana JA; Castillo JR; Abad-Santos F; Payares Herrera C; Sádaba Díaz de Rada B; Gómez Ontañón E
    Eur J Clin Pharmacol; 2010 Jun; 66(6):633-41. PubMed ID: 20204337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events of intravenous immunoglobulin infusions: a ten-year retrospective study.
    Palabrica FR; Kwong SL; Padua FR
    Asia Pac Allergy; 2013 Oct; 3(4):249-56. PubMed ID: 24260730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.